Description
The first ever CoViD-19 vaccine is being rolled out in the country. The session will discuss the efficacy of vaccines currently and prospectively being rolled out. We shall also talk about how CoViD-19 vaccines work and potential safety issues associated with the vaccines to help understand the science and debunk myths surrounding vaccination.
The immunisation is being rolled out in phases and not everyone will get a vaccine imminently and those with underlying medical conditions or contraindications may not benefit from the vaccine. While we wait for the vaccine or a confirmed drug to treat CoViD-19, it may be possible to intervene early to prevent the virus causing a severe disease.
This talk will discuss a simple yet holistic strategy to target the disease during early stages involving a simple yet effective approach in relieving the symptoms of the disease in early stages and reducing the viral load in the upper respiratory tract to help recover from the infection. An early intervention can, therefore, prevent the virus to get down the lower respiratory tract, reduce the number of cases with severe disease involving pneumonia and the need for hospitalisation.
Subject
Public lecture discussing the current and prospective CoViD-19 vaccines, prevention measures and early intervention alternatives to combat the pandemic.
Period | 13 Jan 2021 |
---|
Media contributions
1Media contributions
Title Huddersfield Public Lecture: Living with CoViD-19 Degree of recognition International Media name/outlet Zoom and YouTube Premier Media type Web Duration/Length/Size 1h 53min Country/Territory United Kingdom Date 13/01/21 Producer/Author University of Huddersfield URL https://youtu.be/ipi6FLuHrsU Persons Hamid Merchant
Related content
-
Research output
-
Lactoferrin reduces the risk of respiratory tract infections: A meta-analysis of randomized controlled trials
Research output: Contribution to journal › Article › peer-review
-
CoViD-19: Pharmaceutical care during early disease
Research output: Contribution to journal › Letter › peer-review
-
Can post immunisation increase in acute phase proteins explain the recent thrombotic events with CoViD vaccines?
Research output: Contribution to journal › Letter › peer-review
-
Myocarditis followed by CoViD-19 vaccines: A cause for concern or a reversible minor effect?
Research output: Contribution to journal › Letter › peer-review
-
CoViD-19: An early intervention therapeutic strategy to prevent developing a severe disease as an alternative approach to control the pandemic
Research output: Working paper › Preprint
-
Why Pfizer's or Moderna's CoViD-19 vaccine cannot be 95% effective?
Research output: Contribution to journal › Letter › peer-review
-
Press/Media
-
The future of the university-industry relationship
Press/Media: Public Engagement Activities
-
Can the response to Covid-19 help address other global challenges?
Press/Media: Expert Comment
-
Platelet Disorders and Genetic Vaccines Might Have A Biological Link
Press/Media: Research
-
Vaccines and Rare Clotting Disorders: What's the Link?
Press/Media: Expert Comment